HMGB1 as a potential biomarker and therapeutic target for severe COVID-19

Ruochan Chen*, Yan Huang, Jun Quan, Jiao Liu, Haichao Wang, Timothy R. Billiar, Michael T. Lotze, Herbert J. Zeh, Rui Kang, Daolin Tang*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

110 Scopus citations

Abstract

HMGB1;

Original languageEnglish
Article numbere05672
JournalHeliyon
Volume6
Issue number12
DOIs
StatePublished - Dec 2020
Externally publishedYes

Keywords

  • COVID-19
  • Cell culture
  • Cell death
  • HMGB1
  • Immunology
  • Infectious disease
  • Inflammation
  • Microbiology
  • Virology

Fingerprint

Dive into the research topics of 'HMGB1 as a potential biomarker and therapeutic target for severe COVID-19'. Together they form a unique fingerprint.

Cite this